The Relationship between Obesity and Cardiovascular Risk in Postmenopausal Women

Year 2019, Volume: 11 Issue: 2, 208 - 216, 28.06.2019

Pakize Gamze Erten Bucaktepe Tahsin Çelepkolu İlknur Aslan M.halis Tanrıverdi Ahmet Yılmaz Hamza Aslanhan Veysel Kars

https://doi.org/10.18521/ktd.514048

Abstract

Objective: The
aim of this study was to investigate the relationship between obesity and
cardiovascular risk in postmenopausal women.

            Methods: The study included 43 postmenopausal women who were
admitted to Dicle University Medical School Family Medicine Outpatient Clinic in
2011. Body mass index (BMI), waist and hip circumferences, body fat mass and
percentage, 24-hour arterial tension measurements, homocysteine (Hcy) level,
vitamin B12 level, and Framingham risk score (FRS) were compared between obese
(BMI>30 kg/m²) and non-obese (BMI≤30 kg/m²) patients.

            Results: The patients included 24 (55.8%) obese and 19 (44.2%)
non-obese patients. Abdominal obesity was seen in 29 (67.4%) and truncal
obesity in 33 (76.7%) participants. Family history of cardiac disease was seen
in 25 (58.1%) women, most of whom were obese. Based on FRS, moderate
cardiovascular risk was assessed in 21.6%, but none of the participants were at
high risk. FRS was higher in patients with Hcy levels of ≥15 µmol/L. In
addition, the Hcy values increased with age and there was a negative
correlation between Hcy levels and vitamin B12 status (r=-0.322, p=0.035).

            Conclusion: The results of this study indicate that age- and gender-dependent
differences must be taken into consideration for cardiovascular risk
assessments and postmenopausal women should be informed about obesity and
hypertension in order to improve their quality of life.

Özet

            Amaç:
Bu çalışmada postmenopozal kadınlarda obesite ve kardiyovasküler risk
ilişkisinin incelenmesi amaçlanmıştır.

            Gereç-Yöntem: çalışmaya Dicle Üniversitesi Tıp Fakültesi Aile
Hekimliği Polikliniğine 2011 yılında başvuran 43 postmenopozal kadın dahil
edilmiştir. Beden kitle indeksi (BKİ), bel ve kalça çevresi, vücut yağ kitle ve
yüzdesi, 24-saatlik kan basıncı ölçümleri, homosistein (Hcy) düzeyi, vitamin
B12 düzeyi ve Framingham risk skorlaması (FRS)  obez olan (BKİ>30 kg/m²) ve obez olmayan (BKİ≤30
kg/m²) kadınlarda ölçülerek karşılaştırılmıştır.

Bulgular: Kadınların
24’ü (%55.8) obez ve 19’u (%44.2) non-obezdi. Abdominal obezite 29 (%67.4),
trunkal obezite 33 (%76.7) hastada mevcuttu. Kardiyak hastalık aile öyküsü,
çoğu obez olan 25 (%58.1) kadında tespit edildi. FRS’ye göre orta düzeyde  kardiyovasküler risk %21.6 oranında
saptanırken hiçbir kadın yüksek risk grubunda değildi. FRS, Hcy seviyesi ≥15
µmol/L olan kadınlarda daha yüksekti. Hcy seviyesi yaşla artmaktaydı ve Hcy ile
vitamin B12 arasında negative korelasyon mevcuttu (r=-0.322, p=0.035).

Sonuç: Bu
çalışma kardiyovasküler risk değerlendirmesine yaş ve cinsiyete bağlı
farklılıkların göz önünde bulundurulması ve postmenopozal kadınların, yaşam
kalitelerini arttırmak için obezite ve hipertansiyon konusunda
bilgilendirilmeleri gerektiğini göstermektedir.

Anahtar Kelimeler: Obezite,
Homosistein, Vitamin B12, Kan
basıncı Monitorizasyonu, Framingham Risk Skorlaması.

Keywords

Obesity, Homocysteine, Vitamin B12, Blood Pressure Monitoring

Postmenopozal Kadınlarda Obesite ve Kardiyovasküler Risk İlişkisi

Abstract

References

• Referans 1- Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol. 2004 Jun;93(6):439-53.
• Referans 2- Sclavo M. Cardiovascular risk factors and prevention in women: similarities and differences. Ital Heart J Suppl. 2001 Feb;2(2):125-41.
• Referans 3- Vanuzzo D, Pilotto L, Mirolo R, Pirelli S. Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation. Ital Cardiol (Rome). 2008 Apr;9(4) Suppl 1:6-17.
• Referans 4- Lee LV, Foody JM. Cardiovascular disease in women. Curr Atheroscler Rep. 2008 Aug;10(4):295-302.
• Referans 5- Lomelí C, Rosas M, Mendoza-González C, Lorenzo JA, Pastelín G, Méndez A, Ferez SM, Attie F. Hypertension in women. Arch Cardiol Mex. 2008 Apr-Jun;78 Suppl 2:S2-98-103.
• Referans 6- Sammel MD, Grisso JA, Freeman EW, Hollander L, Liu L, Liu S, Nelson DB and Battistini M. Weight gain among women in the late reproductive years. Family Practice 2003;20(4):401-409.
• Referans 7- Banks AD. Women and heart disease: missed opportunities. J Midwifery Womens Health. 2008 Sep-Oct;53(5):430-9.
• Referans 8- Yanes LL, Reckelhoff JF. Postmenopausal hypertension. Am J Hypertens. 2011 Jul;24(7):740-9.
• Referans 9- Kanai H, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Nagai Y, Fujioka S, Tokunaga K, Tarui S. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension. 1990 Nov;16(5):484-90.
• Referans 10- Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993 Oct 1;119(7 Pt 2):655-60.
• Referans 11- Kang JY, Park IK, Lee JY, Sung SH, Chang YK, Park YK, Choi TI. Use of serum homocysteine to predict cardiovascular disease in Korean men with or without metabolic syndrome. J Korean Med Sci. 2012;27(5):500-505.
• Referans 12- Maxwell SR. Coronary artery disease--free radical damage, antioxidant protection and the role of homocysteine. Basic Res Cardiol. 2000;95 Suppl 1:I65-71.
• Referans 13- Aksoy SN, Geyikli I, Saygili EI. Determinants of plasma homocysteine levels in healthy people. Turk J Biochem. 2006;31(4):175-181.
• Referans 14- Kocabalkan F, Baykal Y, Bozoğlu E. Homocystein as a cardiovascular risk factor in the elderly. Turk Geriatri Derg. 2000;3(2):69-73.
• Referans 15- Park CS, Ihm SH, Yoo KD et al. Relation between c-reactive protein, homocystein levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA. Am J Cardiol 2010 May 1;105(9):1284-8. Doi:10.1016/j.amjcard.2009.12.045. Epub 2010 Mar 11.
• Referans 16- Marosi K, Agota A, Végh V, Joó JG, Langmár Z, Kriszbacher I, Nagy ZB. The role of homocysteine and methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase polymorphisms in the development of cardiovascular diseases and hypertension. Orv Hetil. 2012 Mar 25;153(12):445-53.
• Referans 17- El Oudi M, Aouni Z, Mazigh C, Machghoul S. Total homocysteine levels and cardiovascular risk factors in healthy Tunisians. East Mediterr Health J. 2011 Dec;17(12):937-42.
• Referans 18- Mangoni AA, Jackson SH. Homocystein and cardiovascular disease: current evidence and future prospects. Am J Med. 2002 May;112(7):556-65.
• Referans 19- Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocystein-lowering vitamin supplements. Semin Thromb Hemost. 2000;26(3):341-8.
• Referans 20- VITATOPS Trial Study Group, Hankey GJ, Algra A, Chen C, et al. VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444). Int J Stroke. 2007 May;2(2):144-50.
• Referans 21- Minareci E, Şadan G. The drugs effected homocystein metabolism and drug interactions. Turkiye Klinikleri J Pharm Sci. 2012;1(1):46-58.
• Referans 22- Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009 Jan;30(1):6–15.
• Referans 23- Baumgartner RN, Chumlea WC, Roche AF. Estimation of body composition from bioelectric impedance of body segments. Am J Clin Nutr. 1989 Aug;50(2):221-6.
• Referans 24- Houtkooper LB, Lohman TG, Going SB, et al. Why bioelectrical impedance analysis should be used for estimating adiposity. NIH Technology Assessment Conference. Am J Clin Nutr. 1996 Sep;64 Suppl 3:436-448.
• Referans 25- Han TS, Lean MEJ. Anthropometric indicators of obesity and regional distribution of fat stores. In: Björntorp P, editor. International Textbook of Obesity. Turkish, 1. Eddition by Dursun AN. Istanbul: And Publisment; 2002. p. 51-67.
• Referans 26- Banks AD. Women and heart disease: missed opportunities. J Midwifery Womens Health. 2008 Sep-Oct;53(5):430-9.
• Referans 27- Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951 Mar;41(3):279-81.
• Referans 28- DawberTR, Kannel WB. An epidemiologic study of heart disease: the Framingham study. Nutr Rev. 1958 Jan;16(1):1-4.
• Referans 29- Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
• Referans 30- Kara IH, Baltaci D, Sayin S, Yilmaz A, Celer A, Karacam MS, Memisogullari R, Korkut Y. Invastigation of hematologic and biochemical parameters in obese women in reproductive age. Konuralp Tıp Dergisi. [Konuralp Medical Journal]. 2012;4(1):1-7.
• Referans 31- Ruan X, Jin J, Hua L, Liu Y, Wang J, Liu S. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it. Menopause. 2010 May-Jun;17(3):566-70.
• Referans 32- Tandon VR, Mahajan A, Sharma S, Sharma A. Prevalence of cardiovascular risk factors in postmenopausal women: A rural study. J Midlife Health. 2010 Jan;1(1):26-9.
• Referans 33- Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F, Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. J Endocrinol Invest. 2004 Jul-Aug;27(7):648-53.
• Referans 34- Tonkelaar ID, Seidell JC, van Noord PA, Baanders-van Halewijn EA, Jacobus JH, Bruning PF. Factors influencing waist/hip ratio in randomly selected pre- and post-menopausal women in the dom-project (preliminary results). Int J Obes. 1989;13(6):817-24.
• Referans35- Warren TY, Wilcox S, Dowda M, Baruth M. Independent association of waist circumference with hypertension and diabetes in african american women, South Carolina, 2007-2009. Prev Chronic Dis. 2012 May;9:E105. Doi:http://dx.doi.org/10.5888/pcd9.110170. Epub 2012 May 24.
• Referans 36- Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes Res. 2002 Dec;10(12):1203-6.
• Referans 37- Shimomura T, Wakabayashi I. Associations of cardiovascular risk factors with prehypertension and hypertension in women. Blood Press. 2012 Dec;21(6):345-51. Doi:10.3109/08037051.2012.686177. Epub 2012 May 23.
• Referans 38- Machado Vde S, Valadares AL, Costa-Paiva L, Morais SS, Pinto-Neto AM. Morbidity and associated factors in climacteric women: a population based study in women with 11 or more years of formal education. Rev Bras Ginecol Obstet. 2012 May;34(5):215-20.
• Referans 39- Lyra R, Silva Rdos S, Montenegro Junior RM, Matos MV, Cézar NJ, Fernandes VO, Maurício-da-Silva L. High prevalence of arterial hypertension in a Brazilian Northeast population of low education and income level, and its association with obesity and metabolic syndrome. Rev Assoc Med Bras. 2012 Mar-Apr;58(2):209-14.
• Referans 40- Ekezie J, Anyanwu EG, Danborno B, Anthony U. Impact of urbanization on obesity, anthropometric profile and blood pressure in the Igbos of Nigeria. N Am J Med Sci. 2011 May;3(5):242-6. Doi. 10.4297/najms.2011.3242.
• Referans 41- GHANDEHARI H, LE V, KAMAL-BAHL S, BASSIN SL, WONG ND. ABDOMINAL OBESITY AND THE SPECTRUM OF GLOBAL CARDIOMETABOLIC RISKS IN US ADULTS. INT J OBES (LOND). 2009 FEB;33(2):239-48. DOI:10.1038/IJO.2008.252. EPUB 2008 DEC 9.
• Referans 42- Cagnacci A, Cannoletta M, Palma F, Zanin R, Xholli A, Volpe A. Menopausal symptoms and risk factorsbfor cardiovascular disease in postmenopause. Climacteric. 2012 Apr;15(2):157-62. Doi.10.3109/13697137.2011.617852. Epub 2011 Dec 5.
• Referans 43- Dhonukshe-Rutten RAM, de Vries JHM, de Bree A, van der Put N, van Staveren WA, de Groot LCPGM. Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in Europen populations. Eur J Clin Nutr. 2009 Jan;63(1):18-30. Doi:10.1038/sj.ejcn.1602897. Epub 2007 Sep 12.
• Referans 44- Lietava J, B BV, Dukat A, Fodor GJ. Homocysteine Slovakia study: study design and occurrence of hyperhomocysteinaemia and other risk factors. Bratisl Lek Listy. 2012;113(2):80-6.
• Referans 45- Sengwayo D, Moraba M, Motaung S. Association of homocysteinaemia with hyperglycemia, dyslipidemia, hypertension and obesity. Cardiovasc J Afr. 2013 Aug;24(7):265-9. Doi: 10.58.30/CVJA-2013-059.
• Referans 46- Ikkruthi S, Rajappa M, Nandeesha H, et al. Hyperhomocysteinemia and hiperlipoproteinemia (a) in obese South Indian men: An indication for increased cardiovascular risk. Acta Physiol Hung. 2014 Mar;101(1):13-20. Doi: 10.1556/APhysiol.100.2013.017
• Referans 47- Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S, Afonso L. Homocystein and reclassification of cardiovascular disease risk. Am Coll Cardiol. 2011 Aug 30;58(10):1025-33. Doi:10.1016/jjacc.2011.05.028.
• Referans 48- Ozarda Y, Sucu DK, Hizli B, Aslan D. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell Biochem Funct. 2009 Dec;27(8):568-77. Doi: 10.1002/cbf.1610.